相关实验视频

Updated: May 28, 2025

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Testing Cancer Immunotherapeutics in a Humanized Mouse Model Bearing Human Tumors

Published on: December 16, 2022

结肠癌老年患者的免疫变化和恢复相关因素:试点试验

Byeo Lee Lim¹, Young Il Kim², Jong Lyul Lee²

¹Department of Colon and Rectal Surgery, Seoul Soonchunhyang university hospital, University of Soonchunhyang of Medicine, Seoul, Republic of Korea.

Journal of geriatric oncology

|February 11, 2025

概括

与年轻患者相比,患有结肠癌的老年患者 (≥70岁) 显示出类似或更高水平的免疫因子,如IL-6和自然杀手细胞. 在老年人群中,术后恢复没有负面影响.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
老年病的医生老年病的医生

背景情况:

结肠癌免疫力在年轻和老年患者之间有所不同.
老年患者的术后恢复和免疫力是关键问题.
目前正在为老年结肠癌患者开发个性化治疗策略.

研究的目的:

为了比较70岁以上和70岁以下结肠癌患者之间的免疫学参数.
评估这些年龄组间手术后恢复的差异.
分析恢复,免疫因素和临床特征之间的关联.

主要方法:

75名结肠癌患者接受手术切除的试点研究.
患者分为两个年龄组:≥70岁 (n=29) 和<70岁 (n=46).
对临床病理特征,免疫因素 (IL-6,NK细胞) 和EuroQol-5维度-3 (EQ-5D) 评分的分析.

主要成果:

70岁或以上的年龄组在手术前和手术后的IL-6水平显着更高.
自然杀手 (NK) 细胞的数量在≥70岁的群体中在所有时间点中都始终更高.
两组之间手术前EQ-5D分数没有统计学上显著的差异.

结论:

在老年结肠癌患者 (≥70岁) 中,免疫因素 (IL-6,NK细胞) 不会减少.
在接受结肠癌手术的老年患者中,术后恢复时间不会延长.
老年患者的免疫特征和康复需要进一步研究以获得个性化治疗.

关键词:

年长的老年人.大肠瘤是什么意思豁免权是一种豁免权.恢复功能恢复的功能.

更多相关视频

Predictive Immune Modeling of Solid Tumors

Predictive Immune Modeling of Solid Tumors

Published on: February 25, 2020

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

A Mouse Tumor Model of Surgical Stress to Explore the Mechanisms of Postoperative Immunosuppression and Evaluate Novel Perioperative Immunotherapies

Published on: March 12, 2014

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.